Episode 73- "Alcohol Withdrawal? Try Phenobarbital!": Part 3: An Expert Talks

Recurrent alcohol withdrawal management in the emergency department often involves choosing between phenobarbital, benzodiazepines, or a combination of both. A retrospective study of 642 patient encounters at San Francisco General Hospital reveals that while admission rates and 48-hour return rates remain consistent across all three treatment groups, combining phenobarbital with benzodiazepines significantly extends the emergency department length of stay and increases the likelihood of ICU admission and hypotension. Although phenobarbital serves as a potent benzodiazepine-sparing agent, monotherapy provides a cleaner, more predictable treatment course compared to the synergistic, yet potentially messier, combination approach. Despite the lack of significant differences in initial Clinical Institute Withdrawal Assessment (CIWA) scores, clinical practice often favors single-agent therapy to avoid over-sedation and unnecessary resource utilization, particularly when patients are stable enough for discharge.